A Case of Immune-related Diabetes Induced by Camrelizumab and a Literature Review
Abstract：Programmed death-1 (PD-1) associated fulminant type 1 diabetes (PFD) is a rare and severe complication of tumor immunotherapy. The characteristics of its occurrence and development are still unclear.
Keywords：Immune checkpoint inhibitorsDiabetesT cells
Publication Date：2025-02-27
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 175-176 )